Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandon A Mahal

Showing results (181-190 of 214) with videos related to

Pageof 22
Sort By:
The New England Journal of Medicine|May 23, 2019
Active Surveillance for Low-Risk Prostate Cancer in Black PatientsSantino Butler, Vinayak Muralidhar, Janice Chavez, et al.
European Urology Open Science|May 31, 2022
Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified RaceKevin H Kensler, Shivanshu Awasthi, Mohamed Alshalalfa, et al.
Urologic Oncology|May 22, 2014
Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancerBrandon A Mahal, David R Ziehr, Ayal A Aizer, et al.
The Prostate|April 16, 2025
National Cancer System Characteristics and Prostate Cancer Outcomes: An Analysis of Global DataEdward Christopher Dee, Ranvir Iyengar, Aditya Narayan, et al.
Journal of Geriatric Oncology|May 28, 2014
Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancerBrandon A Mahal, David R Ziehr, Ayal A Aizer, et al.
Prostate Cancer and Prostatic Diseases|September 27, 2024
Evaluating 4Kscore's role in predicting progression on active surveillance for prostate cancer independently of clinical information and PIRADS scoreHelen Y Hougen, Isildinha M Reis, Sunwoo Han, et al.
Urologic Oncology|May 24, 2017
Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomyDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
NEJM Evidence|May 30, 2024
Prostate Cancer Foundation Screening Guidelines for Black Men in the United StatesIsla P Garraway, Sigrid V Carlsson, Yaw A Nyame, et al.
European Urology|February 27, 2018
Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate CancerBrandon A Mahal, David D Yang, Natalie Q Wang, et al.
BJU International|August 16, 2014
Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancerDavid R Ziehr, Ming-Hui Chen, Danjie Zhang, et al.
Pageof 22

Showing results (181-190 of 214) with videos related to

Sort By:
Pageof 22
The New England Journal of Medicine|May 23, 2019
Active Surveillance for Low-Risk Prostate Cancer in Black PatientsSantino Butler, Vinayak Muralidhar, Janice Chavez, et al.
European Urology Open Science|May 31, 2022
Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified RaceKevin H Kensler, Shivanshu Awasthi, Mohamed Alshalalfa, et al.
Urologic Oncology|May 22, 2014
Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancerBrandon A Mahal, David R Ziehr, Ayal A Aizer, et al.
The Prostate|April 16, 2025
National Cancer System Characteristics and Prostate Cancer Outcomes: An Analysis of Global DataEdward Christopher Dee, Ranvir Iyengar, Aditya Narayan, et al.
Journal of Geriatric Oncology|May 28, 2014
Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancerBrandon A Mahal, David R Ziehr, Ayal A Aizer, et al.
Prostate Cancer and Prostatic Diseases|September 27, 2024
Evaluating 4Kscore's role in predicting progression on active surveillance for prostate cancer independently of clinical information and PIRADS scoreHelen Y Hougen, Isildinha M Reis, Sunwoo Han, et al.
Urologic Oncology|May 24, 2017
Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomyDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
NEJM Evidence|May 30, 2024
Prostate Cancer Foundation Screening Guidelines for Black Men in the United StatesIsla P Garraway, Sigrid V Carlsson, Yaw A Nyame, et al.
European Urology|February 27, 2018
Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate CancerBrandon A Mahal, David D Yang, Natalie Q Wang, et al.
BJU International|August 16, 2014
Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancerDavid R Ziehr, Ming-Hui Chen, Danjie Zhang, et al.
Pageof 22